Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

300
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
300
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

762
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
762

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toxicity of Organic Acids Leading to Renal Dysfunction in Glutaric Acidemia Type I: A Mini Review.

Cell biochemistry and function·2026
Same author

On the analysis of adapting deep learning methods to hyperspectral imaging. Use case for WEEE recycling and dataset.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2025
Same author

Clinical Validation Benchmark Dataset and Expert Performance Baseline for Colorectal Polyp Localization Methods.

Journal of imaging·2023
Same author

Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients.

Cancers·2023
Same author

Melanoma and Nevi Subtype Histopathological Characterization with Optical Coherence Tomography.

Life (Basel, Switzerland)·2023
Same author

Exploratory Research on Sweetness Perception: Decision Trees to Study Electroencephalographic Data and Its Relationship with the Explicit Response to Sweet Odor, Taste, and Flavor.

Sensors (Basel, Switzerland)·2022

Related Experiment Video

Updated: Oct 18, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.4K

MRI Deep Learning-Based Solution for Alzheimer's Disease Prediction.

Cristina L Saratxaga1, Iratxe Moya2, Artzai Picón1

  • 1TECNALIA, Basque Research and Technology Alliance (BRTA), Parque Tecnológico de Bizkaia, C/Geldo. Edificio 700, 48160 Derio, Spain.

Journal of Personalized Medicine
|September 28, 2021
PubMed
Summary

This study introduces a novel deep learning method for Alzheimer's diagnosis using MRI scans. The approach achieves high accuracy in identifying the disease and its stage, outperforming existing methods.

Keywords:
Alzheimer’sMRIOASISclassificationdeep learning

More Related Videos

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

413
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.4K

Related Experiment Videos

Last Updated: Oct 18, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.4K
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

413
Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
12:50

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly

Published on: April 14, 2014

40.4K

Area of Science:

  • Neurology
  • Artificial Intelligence
  • Medical Imaging

Background:

  • Alzheimer's disease is a progressive neurodegenerative disorder impacting memory and cognitive functions.
  • Early diagnosis is crucial for initiating timely interventions and management strategies.
  • Magnetic resonance imaging (MRI) is a key tool for Alzheimer's diagnosis, complementing cognitive tests.

Purpose of the Study:

  • To develop and evaluate a novel deep learning-based method for automated Alzheimer's diagnosis using MRI data.
  • To compare the proposed method's performance against existing literature benchmarks.
  • To assess the method's capability in staging Alzheimer's disease severity.

Main Methods:

  • Utilized the Open Access Series of Imaging Studies (OASIS) neuroimaging dataset.
  • Developed a new method integrating deep learning and image processing techniques for MRI analysis.
  • Compared the proposed method's diagnostic and staging accuracy with prior research.

Main Results:

  • Achieved a balanced accuracy (BAC) of up to 0.93 for automated Alzheimer's diagnosis.
  • Attained a BAC of 0.88 for classifying disease stages (healthy, very mild, severe).
  • The proposed method demonstrated superior performance compared to state-of-the-art approaches on the OASIS dataset.

Conclusions:

  • Deep learning strategies offer a powerful approach for robust Alzheimer's-assisted diagnosis.
  • The developed method shows significant potential for clinical application in Alzheimer's detection and staging.
  • This work highlights the effectiveness of AI in analyzing neuroimaging data for neurological disorders.